Abstract
Recurrence of common bile duct stone (CBDS) is not common after laparoscopic common bile duct exploration (LCBDE). This study aimed to investigate the risk factors of recurrence of CBDS after LCBDE. Patients who underwent LCBDE between January 2001 and December 2018 in four teaching hospitals of The Catholic University of Korea were included. The operation, fluoroscopy, and endoscopic retrograde cholangiopancreatography records were investigated retrospectively. The primary outcome of this study was the independent risk factors for recurrence of CBDS. A total of 230 patients were included in this study. Thirty-one patients had recurrence of CBDS. In univariate analysis, CBDS size (>9mm) (P=0.003), multiple stones (≥2) (P=0.031), stone size (≥1.5cm) (P=0.041), CBD diameter (≥12mm) (P=0.005), CBD dilatation (≥10mm) (P=0.02), prior history of laparoscopic cholecystectomy (P=0.002) were associated with recurrence. After multivariable logistic regression, CBDS size (>9mm) (OR 4.67, 95% CI 1.35-16.18, P=0.011), CBD dilatation (≥10mm) (OR 5.66, 95% CI 1.47-21.82, P=0.012), and prior history of laparoscopic cholecystectomy (AOR 3. 90, 95% CI 1.34-11.37, P=0.013) were associated with recurrence. Stone size>9mm, CBD diameter≥10mm, and prior history of laparoscopic cholecystectomy were risk factors for recurrence of CBDS after LCBDE.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.